{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:53:55Z","timestamp":1791075235457,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbi.2024.08.028","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T17:47:52Z","timestamp":1723484872000},"page":"185-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A pentavalent peptide vaccine elicits A\u03b2 and tau antibodies with prophylactic activity in an Alzheimer\u2019s disease mouse model"],"prefix":"10.1016","volume":"122","author":[{"given":"Yiting","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn","family":"Chyn Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Seffouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Willadsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan F.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.08.028_b0005","article-title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis","volume":"372","author":"Ackley","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bbi.2024.08.028_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00688184","article-title":"Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis","volume":"74","author":"Alafuzoff","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2024.08.028_b0015","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2024.08.028_b0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2024.08.028_b0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2024.08.028_b0030","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0035","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41380-021-01409-2","article-title":"Pyroglutamate Abeta cascade as drug target in Alzheimer's disease","volume":"27","author":"Bayer","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2024.08.028_b0040","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbi.2024.08.028_b0045","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbi.2024.08.028_b0050","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","article-title":"Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model","volume":"30","author":"Boutajangout","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2024.08.028_b0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neurobiolaging.2005.12.003","article-title":"Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage","volume":"28","author":"Burbach","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2024.08.028_b0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.10.009","article-title":"Sex differences in \u03b2-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure","volume":"1366","author":"Carroll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2024.08.028_b0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-013-8539-y","article-title":"Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice","volume":"49","author":"Chen","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2024.08.028_b0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2007.06.013","article-title":"Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice","volume":"28","author":"Clinton","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2024.08.028_b0080","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3174\/ajnr.A7586","article-title":"Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice","volume":"43","author":"Cogswell","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbi.2024.08.028_b0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbi.2024.08.028_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","article-title":"Tau passive immunization inhibits not only tau but also Abeta pathology","volume":"9","author":"Dai","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2024.08.028_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315230","article-title":"Gut Microbiota and Immunotherapy for Alzheimer's Disease","volume":"23","author":"Dai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2024.08.028_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13195-019-0556-2","article-title":"Testing a MultiTEP-based combination vaccine to reduce A\u03b2 and tau pathology in Tau22\/5xFAD bigenic mice","volume":"11","author":"Davtyan","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2024.08.028_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D'Hooge","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.bbi.2024.08.028_b0110","doi-asserted-by":"crossref","unstructured":"Doody, R.S., Thomas, R.G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P.S., Siemers, E., Liu-Seifert, H., Mohs, R., Alzheimer's Disease Cooperative Study Steering, C., Solanezumab Study, G., 2014. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med 370, 311-321.","DOI":"10.1056\/NEJMoa1312889"},{"key":"10.1016\/j.bbi.2024.08.028_b0115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0120","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","article-title":"Approval of Aducanumab for Alzheimer Disease-The FDA's Perspective","volume":"181","author":"Dunn","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bbi.2024.08.028_b0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.vaccine.2019.10.073","article-title":"Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes","volume":"38","author":"Federizon","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.bbi.2024.08.028_b0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0135","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2024.08.028_b0140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2024.08.028_b0145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/jcm13051338","article-title":"The Role of Tau Pathology in Alzheimer\u2019s Disease and Down Syndrome","volume":"13","author":"Granholm","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2024.08.028_b0150","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2024.08.028_b0155","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","article-title":"Two novel Tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce Tau protein pathology","volume":"288","author":"Gu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2024.08.028_b0160","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2024.08.028_b0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbi.2024.08.028_b0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003101","article-title":"Immunization with short peptide particles reveals a functional CD8(+) T-cell neoepitope in a murine renal carcinoma model","volume":"9","author":"He","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbi.2024.08.028_b0175","doi-asserted-by":"crossref","first-page":"e19110","DOI":"10.1371\/journal.pone.0019110","article-title":"A Cyclic Undecamer Peptide Mimics a Turn in Folded Alzheimer Amyloid \u03b2 and Elicits Antibodies against Oligomeric and Fibrillar Amyloid and Plaques","volume":"6","author":"Hoogerhout","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2024.08.028_b0180","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41565-018-0271-3","article-title":"A malaria vaccine adjuvant based on recombinant antigen binding to liposomes","volume":"13","author":"Huang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbi.2024.08.028_b0185","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/pathogens11091035","article-title":"Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2","volume":"11","author":"Huang","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.bbi.2024.08.028_b0190","doi-asserted-by":"crossref","first-page":"e2005637","DOI":"10.1002\/adma.202005637","article-title":"SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination","volume":"32","author":"Huang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbi.2024.08.028_b0195","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2024.08.028_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0205","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-021-01546-6","article-title":"Current Status of Clinical Trials on Tau Immunotherapies","volume":"81","author":"Ji","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2024.08.028_b0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11481-008-9114-6","article-title":"Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice","volume":"3","author":"Karlnoski","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2024.08.028_b0215","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","article-title":"Unconventional Secretion Mediates the Trans-cellular Spreading of Tau","volume":"23","author":"Katsinelos","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2024.08.028_b0220","doi-asserted-by":"crossref","unstructured":"Kinney, J.W., Bemiller, S.M., Murtishaw, A.S., Leisgang, A.M., Salazar, A.M., Lamb, B.T., 2018. Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4, 575-590.","DOI":"10.1016\/j.trci.2018.06.014"},{"key":"10.1016\/j.bbi.2024.08.028_b0225","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease","volume":"268","author":"Kopke","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2024.08.028_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152905","article-title":"Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review","volume":"60","author":"Lacaille-Dubois","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbi.2024.08.028_b0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.2022.24494","article-title":"Lecanemab Gains FDA Approval for Early Alzheimer Disease","volume":"329","author":"Larkin","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2024.08.028_b0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-8-36","article-title":"Immunotherapy for Alzheimer's disease: hoops and hurdles","volume":"8","author":"Lemere","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2024.08.028_b0245","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12916-022-02661-1","article-title":"Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine","volume":"20","author":"Lovell","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.bbi.2024.08.028_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2023.11.004","article-title":"One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects","volume":"138","author":"Lovell","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbi.2024.08.028_b0255","doi-asserted-by":"crossref","first-page":"e12112","DOI":"10.1002\/trc2.12112","article-title":"Donanemab (LY3002813) dose-escalation study in Alzheimer's disease","volume":"7","author":"Lowe","year":"2021","journal-title":"Alzheimers Dement (n y)"},{"key":"10.1016\/j.bbi.2024.08.028_b0260","doi-asserted-by":"crossref","first-page":"eabj1476","DOI":"10.1126\/sciadv.abj1476","article-title":"Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice","volume":"7","author":"Mabrouk","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbi.2024.08.028_b0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/YCO.0000000000000223","article-title":"Can anxiety damage the brain?","volume":"29","author":"Mah","year":"2016","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.bbi.2024.08.028_b0270","first-page":"5341375","article-title":"Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine","volume":"2019","author":"Marciani","year":"2019","journal-title":"Research (wash D c)"},{"key":"10.1016\/j.bbi.2024.08.028_b0275","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2024.08.028_bib491","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.immuni.2022.07.015","article-title":"Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody response","volume":"55","author":"McLeod","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2024.08.028_b0280","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2024.08.028_b0285","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2024.08.028_b0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer's disease and Down syndrome","volume":"40","author":"Mondragon-Rodriguez","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbi.2024.08.028_b0295","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease","volume":"112","author":"Monsonego","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2024.08.028_b0300","doi-asserted-by":"crossref","unstructured":"Muhs, A., Hickman, D.T., Pihlgren, M., Chuard, N., Giriens, V., Meerschman, C., van der Auwera, I., van Leuven, F., Sugawara, M., Weingertner, M.-C., Bechinger, B., Greferath, R., Kolonko, N., Nagel-Steger, L., Riesner, D., Brady, R.O., Pfeifer, A., Nicolau, C., 2007. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proceedings of the National Academy of Sciences 104, 9810-9815.","DOI":"10.1073\/pnas.0703137104"},{"key":"10.1016\/j.bbi.2024.08.028_b0305","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0310","article-title":"Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice","volume":"8","author":"Oblak","year":"2022","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.bbi.2024.08.028_b0315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2024.08.028_b0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2024.08.028_b0325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0330","doi-asserted-by":"crossref","unstructured":"Pasquier, F., Sadowsky, C., Holstein, A., Leterme Gle, P., Peng, Y., Jackson, N., Fox, N.C., Ketter, N., Liu, E., Ryan, J.M., Team, A.C.C.S., 2016. Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease. J Alzheimers Dis 51, 1131-1143.","DOI":"10.3233\/JAD-150376"},{"key":"10.1016\/j.bbi.2024.08.028_b0335","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","article-title":"Cerebral hemorrhage after passive anti-Abeta immunotherapy","volume":"298","author":"Pfeifer","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbi.2024.08.028_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105010","article-title":"Passive immunotherapies targeting Abeta and tau in Alzheimer's disease","volume":"144","author":"Plotkin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2024.08.028_b0345","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0350","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/WNL.0000000000001774","article-title":"Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia","volume":"85","author":"Rajan","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2024.08.028_b0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-981-32-9358-8_11","volume":"1184","author":"Ruan","year":"2019","journal-title":"Tau Secretion. Adv Exp Med Biol"},{"key":"10.1016\/j.bbi.2024.08.028_b0360","doi-asserted-by":"crossref","unstructured":"Salloway, S., Sperling, R., Fox, N.C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L.S., Porsteinsson, A.P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I.C., Liu, E., Grundman, M., Yuen, E., Black, R., Brashear, H.R., Bapineuzumab, Clinical Trial, I., 2014. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 370, 322-333.","DOI":"10.1056\/NEJMoa1304839"},{"key":"10.1016\/j.bbi.2024.08.028_b0365","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41592-019-0396-9","article-title":"Software tools for automated transmission electron microscopy","volume":"16","author":"Schorb","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbi.2024.08.028_b0370","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1523\/JNEUROSCI.2377-07.2008","article-title":"Immunotherapy reduces vascular amyloid-beta in PDAPP mice","volume":"28","author":"Schroeter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0375","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12888-015-0497-7","article-title":"The Effects of Stress on Cognitive Aging, Physiology and Emotion (ESCAPE) Project","volume":"15","author":"Scott","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2024.08.028_b0380","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nchem.2236","article-title":"Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens","volume":"7","author":"Shao","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.bbi.2024.08.028_b0385","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nchem.2236","article-title":"Functionalization of cobalt porphyrin\u2013phospholipid bilayers with his-tagged ligands and antigens","volume":"7","author":"Shao","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.bbi.2024.08.028_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043901","article-title":"Efficient Synthesis of Chlorin e6 and Its Potential Photodynamic Immunotherapy in Mouse Melanoma by the Abscopal Effect","volume":"24","author":"Shrestha","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2024.08.028_b0395","doi-asserted-by":"crossref","unstructured":"Sia, Z.R., He, X., Zhang, A., Ang, J.C., Shao, S., Seffouh, A., Huang, W.-C., D\u2019Agostino, M.R., Teimouri Dereshgi, A., Suryaprakash, S., Ortega, J., Andersen, H., Miller, M.S., Davidson, B.A., Lovell, J.F., 2021a. A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proceedings of the National Academy of Sciences 118, e2025759118.","DOI":"10.1073\/pnas.2025759118"},{"key":"10.1016\/j.bbi.2024.08.028_b0400","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025759118","article-title":"A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge","volume":"118","author":"Sia","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2024.08.028_b0405","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2024.08.028_b0410","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2024.08.028_b0415","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.trci.2016.08.001","article-title":"Profiling the dynamics of CSF and plasma A\u03b2 reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor","volume":"2","author":"Timmers","year":"2016","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.bbi.2024.08.028_b0420","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-Amyloid-beta Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2024.08.028_b0425","doi-asserted-by":"crossref","unstructured":"Vandenberghe, R., Rinne, J.O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J.B., Hill, D., Lobello, K., Li, D., McRae, T., Lucas, P., Evans, I., Booth, K., Luscan, G., Wyman, B.T., Hua, L., Yang, L., Brashear, H.R., Black, R.S., Bapineuzumab, Clinical Study, I., 2016. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimers Res Ther 8, 18.","DOI":"10.1186\/s13195-016-0189-7"},{"key":"10.1016\/j.bbi.2024.08.028_b0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043895","article-title":"Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid beta","volume":"24","author":"Vogt","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2024.08.028_b0435","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2024.08.028_b0440","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbi.2024.08.028_b0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0450","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1523\/JNEUROSCI.0695-06.2006","article-title":"Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice","volume":"26","author":"Wilcock","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/187152709787601858","article-title":"Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice","volume":"8","author":"Wilcock","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bbi.2024.08.028_b0460","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.08.028_b0465","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2006.10.020","article-title":"Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid","volume":"144","author":"Wilcock","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2024.08.028_b0470","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1523\/JNEUROSCI.1339-09.2009","article-title":"Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease","volume":"29","author":"Wilcock","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.028_b0475","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bbi.2024.08.028_b0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt237","article-title":"Active immunotherapy options for Alzheimer's disease","volume":"6","author":"Winblad","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2024.08.028_b0485","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-020-00639-w","article-title":"Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3xTg-AD mice","volume":"12","author":"Zhao","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2024.08.028_b0490","article-title":"Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens. Biomedical","author":"Zhou","year":"2023","journal-title":"Journal"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T22:58:45Z","timestamp":1739833125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124005518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":99,"alternative-id":["S0889159124005518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.08.028","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pentavalent peptide vaccine elicits A\u03b2 and tau antibodies with prophylactic activity in an Alzheimer\u2019s disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}